Dec 22, 2020
Two New Members Join MediSieve
MediSieve welcomed Cristina Piñel Neparidze and Danny Gold as new team members.
Cristina is studying BSc Medical Biosciences at Imperial College London. During her 5-month internship she will be working on the sepsis project. She is also a writer for the Imperial Bioscience Review. Her article about the use of Magnetic Blood Filtration as a Promising Treatment for Sepsis can be found here:
https://imperialbiosciencereview.com/2021/02/12/magnetic-blood/
MediSieve hopes that Cristina will enjoy her internship and will find it useful. The company looks forward to implementing her ideas and suggestions.
Danny joined the team as a Simulation Engineer and will work on further developments of MediSieve's products. He will combine his knowledge of Medical Engineering with the Ansys Simulation Software, gained from the partnership with Ansys in the beginning of the month. Danny started out as a laboratory volunteer at UCL and holds a Meng in Bioengineering from the University of Sheffield.
The rest of the team can be found here:
https://www.medisieve.com/About-Us/Team
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
About MediSieve
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
MEDIA CONTACT:
Alina Kagermazova
INVESTOR AND PARTNERSHIP CONTACT:
George Frodsham
